{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:33:30Z","timestamp":1795124010110,"version":"4.10.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder with limited disease-modifying therapies. PANoptosis, an integrated form of programmed cell death involving apoptosis, pyroptosis, and necroptosis, has been implicated in neuroinflammation-related neurodegeneration. However, the roles of PANoptosis-related genes in PD remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed two-sample Mendelian randomization (MR) using cis-eQTL instruments from the eQTLGen Consortium for 30 PANoptosis-related genes, with PD GWAS data from Nalls et al. 2019 as the outcome. Instrumental variables were selected using a hierarchical strategy, with genome-wide significant cis-eQTLs as primary instruments and a relaxed threshold applied only for genes with fewer than three independent SNPs. Sensitivity analyses included MR-Egger, weighted median, MR-PRESSO, MR-RAPS, and leave-one-out analyses. SMR\/HEIDI testing and two-step MR mediation using 731 peripheral immune traits were also performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Genetically predicted higher CXCL16 expression was associated with increased PD risk (OR\u2009=\u20091.115, 95% CI 1.060\u20131.173,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20092.4\u2009\u00d7\u200910\n                      <jats:sup>\u22125<\/jats:sup>\n                      ), while higher FADD expression was associated with reduced PD risk (OR\u2009=\u20090.861, 95% CI 0.790\u20130.939,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20097.1\u2009\u00d7\u200910\n                      <jats:sup>\u22124<\/jats:sup>\n                      ). CASP1 and IFI27 were nominally significant and considered exploratory. Sensitivity analyses were directionally consistent, although MR-Egger estimates were imprecise. SMR\/HEIDI supported CXCL16. Exploratory mediation analysis identified 63\/66 candidate immune mediators after FDR correction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings provide MR-based genetic evidence linking CXCL16 expression to PD risk, with exploratory mediation through peripheral immune phenotypes. The CXCL16\u2013immune cell\u2013PD axis warrants further experimental validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13041-026-01324-z","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:35:42Z","timestamp":1782826542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetically predicted CXCL16 expression is associated with Parkinson\u2019s disease risk and peripheral immune cell dysregulation: a two-sample mendelian randomization study"],"prefix":"10.1186","volume":"19","author":[{"given":"Zhou","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"issue":"4","key":"1324_CR1","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s00415-025-13030-2","volume":"272","author":"L Xu","year":"2025","unstructured":"Xu L, Wang Z, Li Q. Global trends and projections of Parkinson\u2019s disease incidence: a 30-year analysis using GBD 2021 data. J Neurol. 2025;272(4):286.","journal-title":"J Neurol"},{"issue":"1","key":"1324_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12883-025-04191-8","volume":"25","author":"S Peng","year":"2025","unstructured":"Peng S, Liu P, Wang X, et al. Global, regional and national burden of Parkinson\u2019s disease in people over 55 years: a systematic analysis of the global burden of disease study 1991\u20132021. BMC Neurol. 2025;25(1):178.","journal-title":"BMC Neurol"},{"issue":"5","key":"1324_CR3","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, et al. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2021;20(5):385\u201397.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1324_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1353-8020(97)00021-7","volume":"3","author":"KE Lyons","year":"1997","unstructured":"Lyons KE, Pahwa R, Troster AI, et al. A comparison of Parkinson\u2019s disease symptoms and self-reported functioning and well-being. Parkinsonism Relat Disord. 1997;3(4):207\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"1324_CR5","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/mds.29052","volume":"37","author":"P Mahlknecht","year":"2022","unstructured":"Mahlknecht P, Foltynie T, Limousin P, et al. How does deep brain stimulation change the course of Parkinson\u2019s disease? Mov Disord. 2022;37(8):1581\u201392.","journal-title":"Mov Disord"},{"key":"1324_CR6","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.2147\/JIR.S403819","volume":"16","author":"C Shi","year":"2023","unstructured":"Shi C, Cao P, Wang Y, et al. PANoptosis: a cell death characterized by pyroptosis, apoptosis, and necroptosis. J Inflamm Res. 2023;16:1523\u201332.","journal-title":"J Inflamm Res"},{"issue":"8","key":"1324_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.tips.2024.06.002","volume":"45","author":"Q Xiang","year":"2024","unstructured":"Xiang Q, Geng ZX, Yi X, et al. PANoptosis: a novel target for cardiovascular diseases. Trends Pharmacol Sci. 2024;45(8):739\u201356.","journal-title":"Trends Pharmacol Sci"},{"key":"1324_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122158","volume":"333","author":"Z Qi","year":"2023","unstructured":"Qi Z, Zhu L, Wang K, et al. PANoptosis: emerging mechanisms and disease implications. Life Sci. 2023;333:122158.","journal-title":"Life Sci"},{"issue":"1","key":"1324_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/imr.13279","volume":"321","author":"X Sun","year":"2024","unstructured":"Sun X, Yang Y, Meng X, et al. PANoptosis: mechanisms, biology, and role in disease. Immunol Rev. 2024;321(1):246\u201362.","journal-title":"Immunol Rev"},{"issue":"3","key":"1324_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3892\/ijmm.2024.5398","volume":"54","author":"X Gao","year":"2024","unstructured":"Gao X, Ma C, Liang S, et al. PANoptosis: novel insight into regulated cell death and its potential role in cardiovascular diseases (review). Int J Mol Med. 2024;54(3):74.","journal-title":"Int J Mol Med"},{"key":"1324_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114809","volume":"158","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Zhang X, Zhang J, et al. Reduction of D2 receptors on microglia leads to ZBP1-mediated PANoptosis of mPFC in Parkinson\u2019s disease depression mice. Int Immunopharmacol. 2025;158:114809.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"1324_CR12","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.3390\/cells11121885","volume":"11","author":"Y Rajesh","year":"2022","unstructured":"Rajesh Y, Kanneganti TD. Innate immune cell death in neuroinflammation and Alzheimer\u2019s disease. Cells. 2022;11(12):1885.","journal-title":"Cells"},{"issue":"1","key":"1324_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43586-021-00092-5","volume":"2","author":"E Sanderson","year":"2022","unstructured":"Sanderson E, Glymour MM, Holmes MV, et al. Mendelian randomization. Nat Rev Methods Primers. 2022;2(1):1\u201321.","journal-title":"Nat Rev Methods Primers"},{"issue":"9","key":"1324_CR14","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U Vos\u00e4","year":"2021","unstructured":"Vos\u00e4 U, Claringbould A, Westra HJ, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310.","journal-title":"Nat Genet"},{"issue":"12","key":"1324_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease. Lancet Neurol. 2019;18(12):1091\u2013102.","journal-title":"Lancet Neurol"},{"issue":"10","key":"1324_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52(10):1052\u201362.","journal-title":"Nat Genet"},{"key":"1324_CR17","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, et al. 2018 The MR-Base platform supports systematic causal inference across the human phenome. eLife.;7:e34408.","DOI":"10.7554\/eLife.34408"},{"issue":"3","key":"1324_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ije\/dyy258","volume":"48","author":"J Bowden","year":"2019","unstructured":"Bowden J, Del Greco MF, Minelli C, et al. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol. 2019;48(3):728\u201342.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"1324_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"1324_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"1324_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"1324_CR22","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1214\/19-AOS1866","volume":"48","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Wang J, Hemani G, et al. Statistical inference in two-sample summary-data Mendelian randomization using robust adjusted profile score. Ann Stat. 2020;48(3):1742\u201369.","journal-title":"Ann Stat"},{"issue":"5","key":"1324_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48(5):481\u20137.","journal-title":"Nat Genet"},{"issue":"1","key":"1324_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess S, Bowden J, Fall T, et al. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28(1):30\u201342.","journal-title":"Epidemiology"},{"issue":"9","key":"1324_CR25","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s12276-021-00660-5","volume":"53","author":"SSH Yeung","year":"2021","unstructured":"Yeung SSH, Ho YS, Chang RCC. The role of meningeal populations of type II innate lymphoid cells in modulating neuroinflammation in neurodegenerative diseases. Exp Mol Med. 2021;53(9):1251\u201367.","journal-title":"Exp Mol Med"},{"issue":"3","key":"1324_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cytogfr.2014.04.002","volume":"25","author":"MC Izquierdo","year":"2014","unstructured":"Izquierdo MC, Martin-Cleary C, Fernandez-Fernandez B, et al. CXCL16 in kidney and cardiovascular injury. Cytokine Growth Factor Rev. 2014;25(3):317\u201325.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"1324_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1159\/000447935","volume":"41","author":"U Elewa","year":"2016","unstructured":"Elewa U, Sanchez-Ni\u00f1o MD, Mahillo-Fern\u00e1ndez I, et al. Circulating CXCL16 in diabetic kidney disease. Kidney Blood Pressure Res. 2016;41(5):663\u201371.","journal-title":"Kidney Blood Pressure Res"},{"key":"1324_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.atherosclerosis.2015.11.022","volume":"244","author":"LE Laugsand","year":"2016","unstructured":"Laugsand LE, \u00c5svold BO, Vatten LJ, et al. Soluble CXCL16 and risk of myocardial infarction: the HUNT study in Norway. Atherosclerosis. 2016;244:188\u201394.","journal-title":"Atherosclerosis"},{"key":"1324_CR29","doi-asserted-by":"publisher","first-page":"1120034","DOI":"10.3389\/fimmu.2023.1120034","volume":"14","author":"P Zhu","year":"2023","unstructured":"Zhu P, Ke ZR, Chen JX, et al. Advances in mechanism and regulation of PANoptosis: prospects in disease treatment. Front Immunol. 2023;14:1120034.","journal-title":"Front Immunol"},{"key":"1324_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fcimb.2020.00237","volume":"10","author":"S Christgen","year":"2020","unstructured":"Christgen S, Zheng M, Kesavardhana S, et al. Identification of the PANoptosome: a molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:237.","journal-title":"Front Cell Infect Microbiol"},{"issue":"23","key":"1324_CR31","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1242\/jcs.207365","volume":"130","author":"A Malik","year":"2017","unstructured":"Malik A, Kanneganti TD. Inflammasome activation and assembly at a glance. J Cell Sci. 2017;130(23):3955\u201363.","journal-title":"J Cell Sci"},{"issue":"2","key":"1324_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7(2):99\u2013109.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"1324_CR33","doi-asserted-by":"publisher","first-page":"e01356","DOI":"10.1128\/jvi.01356-24","volume":"98","author":"WQ He","year":"2024","unstructured":"He WQ, Pang W, Li N, et al. IFI27 inhibits HIV-1 replication by degrading gag protein through the ubiquitin-proteasome pathway. J Virol. 2024;98(11):e01356-e1424.","journal-title":"J Virol"},{"key":"1324_CR34","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.bbi.2020.01.018","volume":"87","author":"RS Wijeyekoon","year":"2020","unstructured":"Wijeyekoon RS, Kronenberg-Versteeg D, Scott KM, et al. Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson\u2019s disease. Brain Behav Immun. 2020;87:473\u201388.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1324_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","volume":"16","author":"DD \u00c1lvarez-Luqu\u00edn","year":"2019","unstructured":"\u00c1lvarez-Luqu\u00edn DD, Arce-Sillas A, Leyva-Hern\u00e1ndez J, et al. Regulatory impairment in untreated Parkinson\u2019s disease is not restricted to Tregs. J Neuroinflammation. 2019;16(1):212.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"1324_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41531-021-00188-5","volume":"7","author":"AD Thome","year":"2021","unstructured":"Thome AD, Atassi F, Wang J, et al. Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson\u2019s disease. npj Park Dis. 2021;7(1):41.","journal-title":"npj Park Dis"},{"issue":"12","key":"1324_CR37","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.4103\/1673-5374.313057","volume":"16","author":"BY Wang","year":"2021","unstructured":"Wang BY, Ye YY, Qian C, et al. Stress increases MHC-I expression in dopaminergic neurons and induces autoimmune activation in Parkinson\u2019s disease. Neural Regen Res. 2021;16(12):2521\u20137.","journal-title":"Neural Regen Res"},{"issue":"7766","key":"1324_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","volume":"571","author":"D Matheoud","year":"2019","unstructured":"Matheoud D, Cannon T, Voisin A, et al. Intestinal infection triggers Parkinson\u2019s disease-like symptoms in Pink1\u207b\/\u207b mice. Nature. 2019;571(7766):565\u20139.","journal-title":"Nature"},{"issue":"2","key":"1324_CR39","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001125","volume":"9","author":"R Li","year":"2022","unstructured":"Li R, Tropea TF, Baratta LR, et al. Abnormal B-cell and Tfh-cell profiles in patients with Parkinson disease: a cross-sectional study. Neurol Neuroimmunol Neuroinflamm. 2022;9(2):e1125.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"s1","key":"1324_CR40","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.3233\/JPD-223418","volume":"12","author":"KM Scott","year":"2022","unstructured":"Scott KM. B lymphocytes in Parkinson\u2019s disease. J Parkinson\u2019s Dis. 2022;12(s1):S75\u201381.","journal-title":"J Parkinson\u2019s Dis"},{"issue":"1","key":"1324_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12974-016-0632-5","volume":"13","author":"A Sommer","year":"2016","unstructured":"Sommer A, Fadler T, Dorfmeister E, et al. Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model. J Neuroinflamm. 2016;13(1):174.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"1324_CR42","first-page":"182","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadi\u00e8re B, Prigent A, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest. 2009;119(1):182\u201392.","journal-title":"J Clin Invest"},{"issue":"10","key":"1324_CR43","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3390\/cells12101368","volume":"12","author":"C Conte","year":"2023","unstructured":"Conte C, Ingrassia A, Breve J, et al. Toll-like receptor 4 is upregulated in Parkinson\u2019s disease patients and co-localizes with pSer129\u03b1Syn. Cells. 2023;12(10):1368.","journal-title":"Cells"},{"issue":"2","key":"1324_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aag2045","volume":"1","author":"T Kuriakose","year":"2016","unstructured":"Kuriakose T, Man SM, Malireddi RKS, et al. ZBP1\/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol. 2016;1(2):aag2045.","journal-title":"Sci Immunol"},{"issue":"1","key":"1324_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/imr.12909","volume":"297","author":"M Zheng","year":"2020","unstructured":"Zheng M, Kanneganti TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020;297(1):26\u201338.","journal-title":"Immunol Rev"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-026-01324-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:32:08Z","timestamp":1782901928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13041-026-01324-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1186\/s13041-026-01324-z","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable, This study used publicly available, de-identified datasets with prior institutional ethical approval from originating studies. No additional ethical approval or informed consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to publish"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}